Board of Directors and Executive Management


Audited by PwC

Different competencies are represented within Executive Management and the Board of Directors to ensure the best possible management of the company. Members possess broad international management experience, thorough biotech expertise, and in-depth knowledge of Novozymes’ business.

 

EXECUTIVE MANAGEMENT 

 
  ExM-screendump-fra-test.jpg

Per Falholt

Born 1958. Executive Vice President, Research & Development.

Board positions
Member:

IT Practice A/S

 

Benny Loft

Born 1965. Executive Vice President and CFO.

Board positions
Member:

The Blue Planet
Axellia Pharmaceuticals

 

Thomas Nagy

Born in 1963. Executive Vice President, Stakeholder Relations.

Board positions
Member:

The Danish–American Business Forum

 

Thomas Videbæk

Born 1960. Executive Vice President, BioBusiness.

 

Steen Riisgaard

Born 1951. President and CEO.

Board positions
Chairman:

WWF (World Wide Fund for Nature) Denmark
Member:
Egmont International Holding A/S
Rockwool International A/S
EuropaBio

 

Peder Holk Nielsen

Born 1956. Executive Vice President, Enzyme Business.

Board positions
Member:

Hempel A/S


 

Streg-screendump-fra-test.jpg

BOARD OF DIRECTORS

BoD-screendump-fra-test2.jpg  

Michael Munksø

Born 1966. Operator. Employee representative. Member of the Board since 2009. Elected for four years at a time. 

 

Paul Petter Aas

Born 1946. Senior Vice President, Yara International ASA (Norway). Member of the Board since 2000. Elected for one year at a time.

Special competencies:
Extensive international management experience

 

Søren Henrik Jepsen

Born 1947. Regulatory Affairs Manager. Employee representative. Member of the Board since 2005. Elected for four years at a time.

 

Ulla Morin

Born 1954. Laboratory Technician. Employee representative. Member of the Board since 2001. Elected for four years at a time.

 

Henrik Gürtler*

Born 1953. CEO, Novo A/S. Chairman of the Board since 2000. Elected for one year at a time.

Board positions
Chairman:

Copenhagen Airports A/S
COWI A/S
Member:
Novo Nordisk A/S

Special competencies:
In-depth knowledge of Novozymes’ business, and expertise in managing and working in an international biotechnology company

 

 

Walther Thygesen

Born 1950. CEO, Thrane & Thrane A/S. Member of the Board since 2000. Member of the Audit Committee. Elected for one year at a time.

Board positions
Chairman:

Hewlett-Packard Denmark
The Growth Foundation (Vækstfonden)
Member:

Investea Holding A/S

Special competencies:
Expertise in financial matters, and in-depth expertise and wide-ranging international experience within IT

 

Kurt Anker Nielsen*

Born 1945. Vice Chairman of the Board. Chairman of the Audit Committee. Member of the Board since 2000. Elected for one year at a time.

Board positions
Chairman:

Reliance A/S
Member:
The Novo Nordisk Foundation
Member  and Chairman of the audit committee:
Novo Nordisk A/S
Vestas Wind Systems A/S
ZymoGenetics, Inc. (USA)
LifeCycle Pharma A/S

Special competencies:
Expertise in financial and accounting matters, and in-depth knowledge of Novozymes’ business

 

Jerker Hartwall

Born 1952. CEO, AarhusKarlshamn AB (Sweden). Member of the Board since 2000. Member of the Audit Committee. Elected for one year at a time.

Board positions
Chairman:

Aarhus United A/S

Special competencies:
Expertise in financial matters and extensive international management experience 

 

Mathias Uhlén

Born 1954. Professor, the Royal Institute of Technology (Kungliga Tekniska Högskolan), Stockholm (Sweden). Member of the Board since 2007. Elected for one year at a time.

Board positions
Member:

KTH Holding AB
Atlas Antibodies AB
Biotage AB
Affibody AB
Swetree Genomics AB
Nordiag AB
Skanditek Industriförvaltning AB

Special competencies:
Broad experience in research and biotechnology

 

* These board members are not regarded as independent in the sense of the definition contained in the Nørby Report.



My Report